Email This Release
Novaremed Announces U.S. FDA Approval of IND Application to Initiate Phase 2 Clinical Study of NRD135S.E1 for the Treatment of Painful Diabetic Peripheral Neuropathy
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
*
Enter security words: